tiprankstipranks
Fairchem Organics Ltd (IN:FAIRCHEMOR)
:FAIRCHEMOR
India Market
Want to see IN:FAIRCHEMOR full AI Analyst Report?

Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis

1 Followers

Top Page

IN:FAIRCHEMOR

Fairchem Organics Ltd

(FAIRCHEMOR)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
₹623.00
▼(-18.68% Downside)
Action:Reiterated
Date:05/10/26
The score is held back primarily by weakening financial performance (sharp margin and ROE deterioration, with volatile cash generation despite a FY2026 cash-flow rebound). Technicals are supportive with positive momentum and price strength versus key short-term averages, while valuation is only moderately supportive due to a non-meaningful negative P/E and a modest dividend yield.
Positive Factors
Diversified End Markets
Serving multiple end markets (flavors & fragrances, personal care, home care, industrial) and export customers builds durable demand diversification. This B2B, specification-driven model supports repeat orders and reduces single-market dependency, helping stabilize revenue versus pure commodities over a 2–6 month horizon.
Negative Factors
Margin Compression
A multi-year collapse in net margins signals structural pressure from input costs, pricing, or mix shifts. Persistently thin margins reduce reinvestment capacity, weaken pricing power with customers, and erode resilience to raw-material swings, undermining earnings power over a 2–6 month horizon if not remedied.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified End Markets
Serving multiple end markets (flavors & fragrances, personal care, home care, industrial) and export customers builds durable demand diversification. This B2B, specification-driven model supports repeat orders and reduces single-market dependency, helping stabilize revenue versus pure commodities over a 2–6 month horizon.
Read all positive factors

Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)

Fairchem Organics Ltd Business Overview & Revenue Model

Company Description
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, North America, and South America. It provides nutraceuticals comprising natural and mixed tocopherol an...
How the Company Makes Money
Fairchem Organics makes money primarily by selling specialty chemical products to business customers (B2B). Its core revenue stream is product sales from its portfolio of oleochemical derivatives and related specialty chemicals, where earnings are...

Fairchem Organics Ltd Financial Statement Overview

Summary
Financial performance is weak due to a material multi-year deterioration in profitability: revenue declined in FY2026 and net margin fell to ~1.2% (from ~4.1% in FY2025 and ~6–11% in FY2021–FY2024). The balance sheet is still manageable (debt ~0.32x equity), and FY2026 cash flow rebounded to positive operating and free cash flow, but volatile cash conversion and sharply lower ROE (~2.1%) keep the score low.
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
52
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue4.77B4.60B5.38B6.21B6.47B6.42B
Gross Profit702.48M355.37M666.52M1.54B1.56B1.78B
EBITDA228.90M216.17M441.21M681.10M729.68M1.05B
Net Income60.57M55.41M219.74M405.00M435.01M679.06M
Balance Sheet
Total Assets3.88B3.91B4.02B3.34B3.42B3.24B
Cash, Cash Equivalents and Short-Term Investments13.12M12.26M12.86M84.00K838.00K83.00K
Total Debt544.04M837.82M630.32M73.18M501.68M620.30M
Total Liabilities943.42M1.28B997.98M443.77M831.48M919.26M
Stockholders Equity2.94B2.63B3.02B2.90B2.59B2.32B
Cash Flow
Free Cash Flow198.36M229.13M-464.87M563.52M348.89M58.91M
Operating Cash Flow306.58M382.54M-203.78M744.80M496.15M404.85M
Investing Cash Flow-106.46M-140.95M-255.71M-176.25M-144.92M-341.84M
Financing Cash Flow-200.08M-241.53M459.49M-568.55M-351.24M-63.19M

Fairchem Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price766.10
Price Trends
50DMA
549.42
Positive
100DMA
603.71
Negative
200DMA
682.43
Negative
Market Momentum
MACD
14.99
Positive
RSI
55.64
Neutral
STOCH
24.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Neutral. The current price of 766.1 is above the 20-day moving average (MA) of 595.55, above the 50-day MA of 549.42, and above the 200-day MA of 682.43, indicating a neutral trend. The MACD of 14.99 indicates Positive momentum. The RSI at 55.64 is Neutral, neither overbought nor oversold. The STOCH value of 24.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:FAIRCHEMOR.

Fairchem Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
₹10.85B33.580.26%-13.47%-17.39%
64
Neutral
₹9.15B19.710.38%7.76%28.57%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹9.54B3.950.82%13.96%343.65%
60
Neutral
₹6.57B22.241.23%-5.04%-26.70%
60
Neutral
₹8.20B17.042.78%
52
Neutral
₹7.58B101.171.07%-14.55%-74.70%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FAIRCHEMOR
Fairchem Organics Ltd
614.95
-213.41
-25.76%
IN:AMNPLST
Amines & Plasticizers Ltd.
200.00
-24.20
-10.79%
IN:INDOAMIN
Indo Amines Limited
125.15
-15.56
-11.06%
IN:JAYAGROGN
Jayant Agro-Organics Limited
231.20
-29.74
-11.40%
IN:MANALIPETC
Manali Petrochemicals Limited
62.92
6.92
12.36%
IN:VALIANTORG
Valiant Organics Limited
284.85
-92.95
-24.60%

Fairchem Organics Ltd Corporate Events

Fairchem Organics Publishes Audited FY26 Results Extract in Newspapers
May 7, 2026
Fairchem Organics Ltd has reported that its Board of Directors approved the audited financial results for the quarter and full year ended 31 March 2026 at a meeting held on 6 May 2026. The company subsequently published an extract of these audited...
Fairchem Organics Schedules May 7 Call on FY26 Results
Apr 29, 2026
Fairchem Organics Ltd has scheduled an earnings conference call on 7 May 2026 at 3:30 p.m. IST to discuss its audited financial results for the quarter and full year ended 31 March 2026. The call, coordinated by external investor relations adviser...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 10, 2026